What is Ablative Solutions?
Founded in 2011 and based in Wakefield, MA, Ablative Solutions is dedicated to addressing the unmet need in hypertension treatment. The company's proprietary approach targets the overactive sympathetic nervous system, a pathway implicated in hypertension, heart failure, kidney disease, metabolic syndrome, and sleep apnea. Their flagship product, the Peregrine System, is currently under investigation as a therapeutic option for hypertension, designed to complement existing antihypertensive medications. The company's trajectory suggests a strong focus on clinical validation and market penetration within the cardiovascular health sector.
How much funding has Ablative Solutions raised?
Ablative Solutions has raised a total of $149.8M across 9 funding rounds:
Debt
$3M
Series A
$5.4M
Debt
$8M
Series B
$9.5M
Series C
$14.6M
Unspecified
$2.5M
Private Equity
$11.4M
Debt
$4M
Series D
$91.4M
Debt (2011): $3.1M, investors not publicly disclosed
Series A (2012): $5.4M led by BioStar Capital and Michigan Accelerator Fund
Debt (2013): $8M, investors not publicly disclosed
Series B (2014): $9.5M featuring BioStar Capital and Michigan Accelerator Fund I
Series C (2015): $14.6M, investors not publicly disclosed
Unspecified (2015): $2.5M, investors not publicly disclosed
Private Equity (2017): $11.4M, investors not publicly disclosed
Debt (2017): $4M, investors not publicly disclosed
Series D (2022): $91.4M featuring BioStar Capital, Invus Opportunities, and Gilde Healthcare
Key Investors in Ablative Solutions
BioStar Capital
BioStar Capital is a visionary healthcare investor focused on transformative medical devices. The company combines business acumen with clinical expertise, leveraging a collaboration of healthcare clinicians, medical thought leaders, and financial professionals. With over two decades of experience, BioStar Capital is dedicated to producing life-changing outcomes for patients while delivering rewarding returns for investors. Their portfolio showcases innovations that have a significant impact on the medical technology landscape.
Michigan Accelerator Fund
HugeDomains specializes in providing domain names for sale, offering easy and affordable options for clients looking to secure their desired web addresses. They ensure a safe and secure shopping experience with a 30-day money-back guarantee and quick delivery of purchased domains. Their services cater to individuals and businesses seeking to enhance their online presence by acquiring premium domain names. With payment plans available, HugeDomains aims to make domain ownership accessible to a wider audience.
Gilde Healthcare
Gilde Healthcare is a specialized healthcare investment firm managing over €1.4 billion across three fund strategies: Venture & Growth in Healthcare, Private Equity in Healthcare, and Private Equity in Climate Solutions. The firm focuses on investing in businesses that enable better care at lower costs and address planetary challenges through energy transition, biodiversity, and waste management. With a portfolio that includes healthtech, therapeutics, and climate-related companies, Gilde Healthcare aims to support impactful solutions in both sectors. Headquartered in Utrecht, the Netherlands, with offices in Frankfurt, Germany, and Boston, USA, Gilde Healthcare serves clients in the healthcare and climate sectors.
What's next for Ablative Solutions?
With a recent major strategic investment, Ablative Solutions is poised for accelerated growth and the advancement of its clinical programs. This capital infusion is expected to fuel further research and development, support regulatory processes, and potentially expand commercialization efforts for the Peregrine System. The company's focus on a significant unmet medical need in hypertension positions it for substantial impact and market capture, contingent on successful clinical outcomes and strategic market entry.
See full Ablative Solutions company page
